| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
German Cancer Research Center, Institute of Experimental Pathology, Im Neuenheimer Feld 280, D-6900 Heidelberg, West Germany
In a modified two-stage carcinogenesis experiment, the effectiveness of the initiator 7,12-dimethylbenz(a)anthracene (DMBA) and the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) in the epithelium of the forestomach of the mouse has been investigated.
Fifty mice were treated intragastrically with a single dose of DMBA (50 mg/kg body weight), followed by repeated intragastric administration of TPA (10 mg/kg body weight) over a period of 35 weeks. In comparison with the corresponding control groups (no treatment, DMBA initiation only, and TPA treatment only), the initiated and promoted group clearly showed the highest tumor incidence in the target organ (45 tumor-bearing animals of 50 animals). No tumors of the forestomach were found in the untreated control group and the TPA-treated group, whereas in the DMBA-initiated group, ten animals had developed tumors of the forestomach.
In addition to the mouse skin model for two-stage carcinogenesis, the mouse forestomach appears to respond to DMBA initiation-TPA promotion. This organ provides and additional tissue with which to investigate tumor promotion and further to ascertain specific parameters of the promotion step.
1 To whom requests for reprints should be addressed.
Received 9/11/78. Accepted 12/28/78.
This article has been cited by other articles:
![]() |
K. Takaba, K. Saeki, K. Suzuki, H. Wanibuchi, and S. Fukushima Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate Carcinogenesis, April 1, 2000; 21(4): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Fabre and A Garcia de Herreros Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin J. Cell Sci., January 10, 1993; 106(2): 513 - 521. [Abstract] [PDF] |
||||
![]() |
A. DeLa Herreros, M Fabre, E Batlle, C Balague, and F. Real The tumor promoter 12-O-tetradecanoylphorbol-13-acetate blocks differentiation of HT-29 human colon cancer cells J. Cell Sci., January 8, 1993; 105(4): 1165 - 1172. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |